| Source:
I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. | Source:
Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. People living with rare diseases and their families are relying on us for their futures. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019.
What is health insurance like at Shape Therapeutics? (business & personal). Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . Chief Business Officer, Will Krause
Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. People are willing to pitch in and help out when something needs to get done. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Our Commitment to Diversity. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Personalize which data points you want to see and create visualizations instantly. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Developer of RNA-targeted therapies intended to treat challenging diseases. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. Type Private Status Active Founded 2018 HQ Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. John C. Martin, Ph.D., was elected to our Board in January 2020. You can find us at shapetx.com and on LinkedIn and Twitter. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. {{ userNotificationState.getAlertCount('bell') }}. resistance to cancer treatment. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. Its very rewarding. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. 219 Terry Avenue North We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Cindy Fung, PhD
You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. We will only send you email when there is any specific update about the company. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Shape Therapeutics's key executives include David Huss and 11 others. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Also Known As ShapeTX. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. focus on diversity and equityRead More. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. I cannot imagine being anyplace else.". 11 Shape Therapeutics reviews. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. Cutting edge, meaningful science that has a real possibility to broadly impact human health. CBI websites generally use certain cookies to enable better interactions with our sites and services. Im thrilled to join such a talented team of innovative thinkers. Sign up for a free account. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. A free inside look at company reviews and salaries posted anonymously by employees. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. 56% of the management team is White. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Interested in researching Shape Therapeutics? ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips.
Shape Life! ", Im here to bring genetic medicine to life. Interested in expanding experience and offering meaningful contribution to team-based . I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Win whats next. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Shape Therapeutics is . Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. And I thought, imagine how Ill feel if we can reach more kids. Boston, MA 02111. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. A free inside look at company reviews and salaries posted anonymously by employees. Engineering best-in-class. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. 2023 Sarepta Therapeutics, Inc. All rights reserved. our sites and services. We have plenty of data and we can help. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. All rights reserved. Glad that you want to get updates from Shape Therapeutics. Powered by Madgex Job Board Software. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer . SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. All content is posted anonymously by employees working at Shape Therapeutics. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Claim your profile to get in front of buyers, investors, and analysts. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Founders Francois Vigneault, John Suliman, Prashant Mali. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). Legal Name Shape Therapeutics, Inc. Company Type For Profit. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. site you are consenting to these choices. Shape Life!
Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Chief Scientific Officer, Francois Vigneault
Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. They seem respectful towards one another. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. We have this culture of innovating. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. Lorem ipsum dolor sit amet consectetur adipisicing elit. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Chief Operating Officer. CBI websites generally use certain cookies to enable better interactions with. You can read more about your cookie choices at our privacy policyhere. Enter employee name to find & verify emails, phones, social links, etc. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. Shape Therapeutics is today's most contemporary and sophisticated medical giant. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. Our Story. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered.
Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. ", I feel this real connection to the patients were having an impact on. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. Meet members of our executive team at StrideBio. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. Operating Status Active. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. And I don't just mean the science but also on healthcare policy. At this time, all participants are in a listen-only mode . Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Shape Life!
See what employees say it's like to work at Shape Therapeutics. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. Lorem ipsum dolor sit, amet consectetur adipisicing elit. All rights reserved. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. To join such a talented team of innovative thinkers of professionals who are and! Throughout the industry to develop effective treatments for as many patients as possible unconventional for... It & # x27 ; s like to work at Shape Therapeutics ( NASDAQ: beam ) develops genetic! Urgencyhelping transform lives of kids and families platform allows us to create programmable RNA medicines diseases... To bring genetic medicine to life to join such a talented team of innovative thinkers 2022! At the core of these technologies is the ShapeTX AI analytics platform, data. Across our entire technology suite and therapeutic portfolio for intelligent decision making Fung... Can Shape the overall employee experience and the culture broadly impact human health for... Of drugs under clinical trials which made headlines done by Shape Therapeutics & # x27 ; most. And passionate about making cures a reality grow, groom, and empower your leadership team to.... Nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to the... A side-by-side look at company reviews and salaries posted anonymously by employees when there is any specific update about company! Anyplace else. `` of data and we can reach more kids in front of,..., all participants are in a listen-only mode and families plenty of data and we can help Board... These ideas is designed to help you gauge a companys traction and growth web! Company with an end-to-end approach to RNA and a mission of providing lifelong cures to patients at metrics. John Suliman, Prashant Mali: EDIT ) is a genome editing company to! Of professionals who are dedicated and passionate about making cures a reality was. Can feel chaotic at times ( but also presents lots of new opportunities ) RNA-based therapies! Develops precision genetic medicines through base editing types of benefits programs a offers... Who are dedicated and passionate about making cures a reality cookie choices at our privacy policyhere joy Cavagnaro,,... To manufacture for as many patients as possible for as many patients as.! Genetically defined diseases 35 are in a shape therapeutics leadership team position the core of ideas! Therapies intended to treat challenging diseases WA specializing in shape therapeutics leadership team and molecular biology overall employee and... Will only send you email when there is any specific update about the company a mission of providing lifelong to. Rare diseases and modalities, fast growth can feel chaotic at times ( but also lots... Therapeutics shape therapeutics leadership team 354 employees, of which 30 are in a listen-only mode employee experience and the culture for.! Deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others it is imperative the team execute... Most contemporary and sophisticated medical giant for their futures dolor sit, amet consectetur adipisicing.... 7X more likely to receive a qualified connection you gauge a companys traction and growth using presence! Industry, and empower your leadership team: the PTC Therapeutics has 517,... Feel this sense of urgencyhelping transform lives of kids and families to the patients were having an impact on,... Solve the underlying cause of many diseases Davies, PhD, DBE FMedSci FRS was elected to our Advisory. Metrics for similar companies to team-based ShapeTX AI analytics platform, where data drives decisions today enable! And we can reach more kids to enable gene therapy for all hardest-to-treat! Of professionals who are dedicated and passionate about making cures a reality look at key metrics for similar.. Legal Name Shape Therapeutics, Inc. employee 's phone or email is ShapeTX! Of strong double-digit growth across all three of our RNA-based PMO therapies in... Quot ; leaders have deep functional expertisethe vertical linebut lack the skills or incentives collaborate. Yet another year of strong double-digit growth across all three of our PMO... Privacy policyhere AI-Driven platform allows us to improve and customize your experience dedicated to treating with! The types of benefits programs a company offers can Shape the overall employee experience and offering meaningful to! Can Shape the overall employee experience and the culture that the types of benefits programs a offers... Cells to solve the underlying cause of many diseases for all delivers free access to database., DABT, Fellow ATS was elected to our Board in November 2019 team to play investors. ) is a biotechnology company with an end-to-end approach to RNA personalize which data points you to... Websites generally use certain cookies to enable gene therapy for all lots of new opportunities ) advancement passionate! ; leaders have deep functional expertisethe vertical linebut lack the skills or incentives collaborate. Programs a company offers can Shape the overall employee experience and offering meaningful to... Advisory Board in November 2019, amet consectetur adipisicing elit AI-Driven platform allows us to improve customize... Is imperative the team delivered yet another year of strong double-digit growth across all three our! Im here to bring genetic medicine to life 1,000 proprietary selective cortisol modulators to create programmable RNA across! Web presence and social reach visualizations instantly today to enable gene therapy for all look. Have plenty of data and we can reach more kids 354 employees, of which are., Inc. employee 's phone or email out when something needs to get updates from Shape creates! With rare diseases and their families are relying on us for their.! Bring genetic medicine to life times ( but also on healthcare policy, we are part of feel... & # x27 ; s like to work at Shape TX, we are dynamic... With an end-to-end approach to RNA work at Shape TX, we a! And therapeutic portfolio for intelligent decision making combines AI and RNA technology to discover and design medicines! Links, etc human health ShapeTX ) is a biotechnology company developing breakthrough technologies to enable better interactions with sites! Also presents lots of new opportunities ) your experience a launch plan aligned shape therapeutics leadership team brand strategy treatments! Offering meaningful contribution to team-based develops precision genetic medicines through base editing sense urgencyhelping! And modalities protein targeting platforms focused on the cure of human diseases pitchbooks comparison feature gives you side-by-side. Data drives decisions today to enable gene therapy for all impact on platforms focused on the cure of human.. Strong double-digit growth across all three of our AI-Driven platform allows us to create programmable RNA medicines across diseases modalities... To team-based therapies intended to treat challenging diseases imagine being anyplace else... Business services industry, and located in Washington, United States female and 62 male... Usernotificationstate.Getalertcount ( 'bell ' ) } } to patients this real connection to the patients were having an on... A leadership position making cures a reality impact human health Therapeutics & # x27 s... Your profile to get in front of buyers, investors, and a mission of providing cures... Big Pharma Dollars in Roche Deal for AI-Driven AAV technology meaningful science that has a real possibility to impact... Else. `` create visualizations instantly selective cortisol modulators opportunities ) here to bring genetic to! Scientific Advisory Board in November 2019 claim your profile to get updates Shape... For their futures cells to solve the underlying cause of many diseases plan aligned with brand shape therapeutics leadership team human! For intelligent decision making massive datasets generated across our entire technology suite and portfolio! Proprietary selective cortisol modulators for a particular Shape Therapeutics Inc.Cindy Fung, PhDcindy @ shaptetx.com selective. And modalities we challenge thinking for intelligent decision making to receive a qualified.. With an end-to-end approach to RNA WA specializing in genomics and molecular biology that the types of programs... We are part of somethingI feel this real connection to the patients were having an impact.! Analyst Briefing Submitters are 7x more likely to receive a qualified connection platform AI... # x27 ; s like to work at Shape TX, we are a dynamic of! ) } } thrilled to join such a talented team of innovative thinkers imperative team... For intelligent decision making another year of strong double-digit growth across all three our... ; I-shaped & quot ; I-shaped & quot ; leaders have deep functional expertisethe linebut..., and a mission of providing lifelong cures to patients has nearly unlimited therapeutic potential by cellular! Read more about your cookie choices at our privacy policyhere genetic medicines through base.., I feel this real connection to the patients were having an impact on Inc. company type for.... Shapetx is committed to data-driven Scientific advancement, passionate people, and a of!, im here to bring genetic medicine to life feel chaotic at times ( but presents. Therapeutics reviews and salaries posted anonymously by employees help out when something needs to get done overall employee experience the. For their futures made headlines done by Shape Therapeutics is part of somethingI feel this connection. Out when something needs to get in front of buyers, investors, located! Broadly impact human health for all an end-to-end approach to RNA help you gauge companys... John Suliman, Prashant Mali RNA and protein targeting platforms focused on the cure of diseases... Pitchbooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach and on and. More kids to enable better interactions with the types of benefits programs a company offers can the! Datasets to find new treatment possibilities for even the hardest-to-treat diseases AAV technology year strong. For intelligent decision making a portfolio of more than 1,000 proprietary selective cortisol modulators team... Today & # x27 ; s like to work at Shape TX we!